High dosage of a powerful class of antibiotics administered to treat cystic fibrosis may significantly increase the risk of permanent hearing loss, a new study has warned.
Cystic fibrosis (CF) is an inherited life-threatening disorder that damages the lungs and digestive system. About 70,000 people worldwide are living with the disease.
The study, by researchers from Oregon Health & Science University, U.S., suggests that physicians who treat patients with CF may be able to consider alternative strategies for treating the symptoms of respiratory infections associated with CF, especially if patients are responsive to different classes of antibiotics.
